Limited Sources Justification (LSJ): Firm Fixed-Price, Non-Personal Service Type, Commercial Item DO/TO to provide Immunoassay Reagents, Supplies, and Cost Per Reportable Result Analyzer Services for the Standing Rock Service Unit (SRSU), IHS Hospital.
Indian Health Service · GREAT PLAINS AREA INDIAN HEALTH SVC
Materiality: <0.01% of $ABT revenue (Low) SEC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation RFQ-25-001 in this department, oldest first.
- Nov 21, 2024Sources SoughtOpen
- Jan 8, 2025 · this noticeAward NoticeABBOTT LABORATORIES INC. · $22K
- Jan 8, 2025Justification (Sole Source)Open
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Firm Fixed-Price, Non-Personal Service Type, Commercial Item Delivery/Task Order to provide Immunoassay Reagents, Supplies, and Cost Per Reportable Result Analyzer Services (Architect i1000SR) for the Standing Rock Service Unit (SRSU), Fort Yates IHS Hospital, Fort Yates, North Dakota. Period of Performance: 01/01/2025 - 12/31/2025. * FAR 8.405-6(a)(1)(i)(B)); Only one source is capable of providing the supplies or services required at the level or quality required because the supplies or services are unique or highly specialized (FAR 8.405-6(a)(1)(i)(B)).
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Indian Health Service), same product/service code (PSC) 6550.
Single-winner award sizes (3): middle half $80K to $147K, median $80K; range $80K to $215K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $3.0B | 2 | $160K | May 28, 2025 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $215K | Sep 11, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 3 past awards, $80K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 11, 2026GOVERNMENT SCIENTIFIC SOURCE INC$215KLaboratory Quality Control Materials - Zuni Comprehensive Community Health Center (ZCCHC)No listed company matched (Materiality N/A)
- May 28, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low) SEC
- May 19, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$80KBrand Name or Equal Ortho Diagnostics Blood Bank and Quality Control Supplies, IHS, Hopi Health Care Center, 5-Year BPAMateriality: <0.01% of $QDEL revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Indian Health Service since 2024 (0 filings)
- 0 of their lobbyists list a past Indian Health Service job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 2 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.